Tuula Pirttilä

Best Publications

• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

  1417
  Citations

• Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

  Tero Tapiola;Irina Alafuzoff;Sanna-Kaisa Herukka;Laura Parkkinen

  1030
  Citations

• Plasma and cerebrospinal fluid Levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease

  Pankaj D. Mehta;Tuula Pirttilä;Sangita P. Mehta;Eugene A. Sersen

  865
  Citations

• Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

  Pieter Jelle Visser;Pieter Jelle Visser;Frans Verhey;Dirk L Knol;Philip Scheltens

  814
  Citations

• CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

  Katharina Buerger;Michael Ewers;Tuula Pirttila;Raymond Zinkowski

  737
  Citations

• Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance

  Laura Parkkinen;Tuula Pirttilä;Irina Alafuzoff

  412
  Citations

• Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

  Katharina Buerger;Raymond Zinkowski;Stefan J. Teipel;Tero Tapiola

  360
  Citations

• Amyloid β protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

  P.D Mehta;T Pirttila;B.A Patrick;M Barshatzky

  332
  Citations

• Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia

  Laura Parkkinen;Tarja Kauppinen;Tuula Pirttilä;Jaana M. Autere

  318
  Citations

• Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.

  Kristiina Karttunen;Pertti Karppi;Asta Hiltunen;Matti Vanhanen

  297
  Citations

• Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

  Ville Leinonen;Irina Alafuzoff;Sargo Aalto;Timo Suotunen

  295
  Citations

• CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.

  Sanna-Kaisa Herukka;Merja Hallikainen;Hilkka Soininen;Tuula Pirttilä

  285
  Citations

• Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

  Elina M Sutinen;Tuula Pirttilä;George Anderson;Antero Salminen

  259
  Citations

• Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients

  Johanna Ojala;Irina Alafuzoff;Sanna-Kaisa Herukka;Thomas van Groen;Thomas van Groen

  255
  Citations

• Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.

  Khalid Iqbal;Michael Flory;Sabiha Khatoon;Hilkka Soininen

  221
  Citations

• A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.

  N. A. Verwey;W M van der Flier;K Blennow;C Clark

  206
  Citations

• Association Between Blood Pressure and Survival over 9 Years in a General Population Aged 85 and Older

  Sari Rastas;Tuula Pirttilä;Petteri Viramo;Auli Verkkoniemi

  201
  Citations

• Proteomic analysis of protein oxidation in Alzheimer's disease brain.

  Minna A. Korolainen;Gundars Goldsteins;Irina Alafuzoff;Jari Koistinaho

  190
  Citations

• Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

  Ville Leinonen;Anne M. Koivisto;Anne M. Koivisto;Sakari Savolainen;Jaana Rummukainen

  190
  Citations

• Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

  Terho Lehtimäki;Tuula Pirttilä;Pankaj D. Mehta;Henryk M. Wisniewski

  178
  Citations

• Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease

  Tero Tapiola;Tuula Pirttilä;Mia Mikkonen;Pankaj D. Mehta

  176
  Citations